ENDOMETABOLIC SOLUTIONS, INC.

Profile

Company Names

ENDOMETABOLIC SOLUTIONS, INC.

Addresses

10813 MAJOR AVENUE NORTH, BROOKLYN PARK, MN 55443

Phone Numbers

763-425-3741

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DE

Total Amount Raised:

$3,826,650.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2009-01-30 
$3,826,650.00 
$3,826,650.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
J. 
BLAESER 
EXECUTIVE OFFICER, DIRECTOR
ENDOMETABOLIC SOLUTIONS, INC.
MICHEL 
 
GAGNER 
EXECUTIVE OFFICER, DIRECTOR
ENDOMETABOLIC SOLUTIONS, INC.   |  GT METABOLIC SOLUTIONS INC
PETER 
 
MCNERNEY 
DIRECTOR
ENDOMETABOLIC SOLUTIONS, INC.   |  TORAX MEDICAL INC   |  M2 GROUP HOLDINGS INC   |  CNS THERAPEUTICS INC   |  AXIOMED SPINE CORP   |  INTUITY MEDICAL, INC.   |  EMPATHETICS, INC.
DALE 
A. 
SPENCER 
EXECUTIVE OFFICER, DIRECTOR
ENDOMETABOLIC SOLUTIONS, INC.   |  CARDIAC CONCEPTS INC
KATHY 
 
TUNE 
DIRECTOR
ENDOMETABOLIC SOLUTIONS, INC.   |  VERTIFLEX INC   |  VERTIFLEX, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2009-02-17
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2009-01-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#